315 related articles for article (PubMed ID: 10557476)
1. Prescription costs become harder to swallow. Providers and payers get a big dose of reality with explosive spending and patient demand for new drugs.
Hensley S
Mod Healthc; 1999 Aug; 29(34):30-4. PubMed ID: 10557476
[TBL] [Abstract][Full Text] [Related]
2. Marketplace. Managed care plans try to cope as drug ads spur patient demand.
Moskowitz DB
Med Health; 1998 May; 52(20):suppl 1-2. PubMed ID: 10179010
[No Abstract] [Full Text] [Related]
3. Managing drug costs: the perception of managed care pharmacy directors.
Litton LM; Sisk FA; Akins ME
Am J Manag Care; 2000 Jul; 6(7):805-14. PubMed ID: 11067377
[TBL] [Abstract][Full Text] [Related]
4. The effect of newer drugs on health spending: do they really increase the costs?
Civan A; Köksal B
Health Econ; 2010 May; 19(5):581-95. PubMed ID: 19404925
[TBL] [Abstract][Full Text] [Related]
5. Prescription drug spending: contribution to health care spending and cost containment strategies.
Rivers PA; Hall NG; Frimpong J
J Health Care Finance; 2006; 32(3):8-19. PubMed ID: 18975728
[TBL] [Abstract][Full Text] [Related]
6. Health care spending: can the United States control it?
Altman SH; Wallack SS
Baxter Health Policy Rev; 1996; 2():1-32. PubMed ID: 11066257
[TBL] [Abstract][Full Text] [Related]
7. Managing prescription drug costs.
Sica JM
Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515
[TBL] [Abstract][Full Text] [Related]
8. By the numbers. The rising costs of prescription drugs.
Thornton D
Healthplan; 1999; 40(5):71-2. PubMed ID: 10622972
[No Abstract] [Full Text] [Related]
9. Why more cost-sharing won't slow Medicare spending.
Chulis GS; Eppig FJ; Hogan MO; Waldo DR; Arnett RH
J Am Health Policy; 1993; 3(4):15-20. PubMed ID: 10127492
[TBL] [Abstract][Full Text] [Related]
10. Escalating need for comparative analysis of drugs within a therapeutic class.
Giaquinta D
Manag Care Interface; 2003 Oct; 16(10):32-4. PubMed ID: 14606258
[No Abstract] [Full Text] [Related]
11. Trends in mental health cost growth: an expanded role for management?
Frank RG; Goldman HH; McGuire TG
Health Aff (Millwood); 2009; 28(3):649-59. PubMed ID: 19414870
[TBL] [Abstract][Full Text] [Related]
12. Health care in the United States: current and future challenges.
Luke RT
Manag Care; 2001 Oct; 10(10 Suppl):2-6. PubMed ID: 11729444
[TBL] [Abstract][Full Text] [Related]
13. Controlling the cost of branded drugs.
Mandelker J
Bus Health; 1993 Nov; 11(13):44-6, 48. PubMed ID: 10130506
[TBL] [Abstract][Full Text] [Related]
14. Stats & facts. More consumer cost sharing in pharmacy benefit.
Manag Care Interface; 2002 Apr; 15(4):34-5. PubMed ID: 11979701
[No Abstract] [Full Text] [Related]
15. Increasing stakes and complex dynamics in the formulary process.
Tadlock C
Manag Care Interface; 2007 Mar; 20(3):12, 14. PubMed ID: 17458473
[No Abstract] [Full Text] [Related]
16. Managed care guidelines for the economic evaluation of pharmaceuticals.
Langley PC; Martin RE
Am J Manag Care; 1997 Jul; 3(7):1013-21. PubMed ID: 10173366
[TBL] [Abstract][Full Text] [Related]
17. States' control of prescription drug spending: a heterogeneous approach.
Morden NE; Sullivan SD
Health Aff (Millwood); 2005; 24(4):1032-8. PubMed ID: 16012143
[TBL] [Abstract][Full Text] [Related]
18. National drug bill to continue rising by 14%-18%.
Manag Care; 2003 Jul; 12(7):52. PubMed ID: 12891957
[No Abstract] [Full Text] [Related]
19. Integrating new technology without going broke.
Starr C
Bus Health; 2002; 20(1):29-34. PubMed ID: 12534112
[No Abstract] [Full Text] [Related]
20. Drug cost increases are generated by the 50 top selling pharmaceuticals.
Health Care Strateg Manage; 2001 Jun; 19(6):14-5, 1. PubMed ID: 11409091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]